AROMICS renews the Seal for Innovative SMEs
The Spanish Ministry of Science, Innovation and Universities recognized the innovation and advances of Aromics in developing novel therapies for highly unmet medical needs. The seal awards companies that have proven, with its trajectory and activity, to comply with the requirements of resources dedicated to innovative projects obtaining optimal results. As a consequence, the biotech is being inscribed in Innovative SME public register. Currently AROMICS is completing the preclinical stage of a new compound (NAX035) for malignant mesothelioma, a rare and aggressive cancer linked to asbestos exposure.